Average Daily Risk Range as a Measure of Glycemic Risk is Associated with Mortality in the Intensive Care Unit: A Retrospective Study in a Burn Intensive Care Unit

Abstract

Background:

Although tight glycemic control has been associated with improved outcomes in the intensive care unit (ICU), glycemic variability may be the influential factor in mortality. The main goal of the study was to relate blood glucose (BG) variability of burn ICU patients to outcomes using a sensitive measure of glycemic variability, the average daily risk range (ADRR).

Method:

Data from patients admitted to a burn ICU were used. Patients were matched by total body surface area (TBSA) and injury severity score (ISS) to test whether increased BG variability measured by ADRR was associated with higher mortality risk and whether we could identify ADRR-based classifications associated with the degree of risk.

Results:

Four ADRR classifications were identified: Low risk, medium-low, medium-high, and high. Mortality progressively increased from 25% in the low-risk group to over 60% in the high-risk group (p < .001). In a post hoc analysis, age also contributed to outcome. Younger (age < 43 years) survivors and nonsurvivors matched by TBSA and ISS had no significant difference in age, mean BG or standard deviation of BG; however, nonsurvivors had higher ADRR (p < .01).

Conclusions:

Independent of injury severity, glycemic variability measured by the ADRR was significantly associated with mortality in the ICU. When age was considered, ADRR was the only measure of glycemia significantly associated with mortality in younger patients with burns.

Keywords

average daily risk range burn critical illness glucose control glucose variability glycemic risk

References

Van den Berghe

Wouters

Weekers

Verwaest

Bruyninckx

Schetz

Vlasselaers

Ferdinande

Lauwers

Bouillon

. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345 (19): 1359–67.

Finney

Zekveld

Elia

Evans

. Glucose control and mortality in critically ill patients. JAMA. 2003;290 (15): 2041–7.

Reed

Stewart

Sherman

Myers

Corneille

Larson

Gerhardt

Beadle

Gamboa

Dent

Cohn

Pruitt

Jr.

Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg. 2007;204 (5): 1048–55.

Finfer

Heritier

; NICE Study Management Committee and SUGAR Study Executive Committee. The NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) Study: Statistical analysis plan. Crit Care Resusc. 2009;11 (1): 46–57.

Wolfe

Durkot

Allsop

Burke

. Glucose metabolism in severely burned patients. Metabolism. 1979;28 (10): 1031–9.

Gore

Chinkes

Heggers

Herndon

Wolf

Desai

. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51 (3): 540–4.

Herndon

Tompkins

. Support of the metabolic response to burn injury. Lancet. 2004;363 (9424): 1895–902.

Pham

Warren

Phan

Molitor

Greenhalgh

Palmieri

. Impact of tight glycemic control in severely burned children. J Trauma. 2005;59 (5): 1148–54.

Jeschke

Chinkes

Finnerty

Kulp

Suman

Norbury

Branski

Gauglitz

Mlcak

Herndon

. Pathophysiologic response to severe burn injury. Ann Surg. 2008;248 (3): 387–401.

10.

Atiyeh

Gunn

Dibo

. Metabolic implications of severe burn injuries and their management: A systematic review of the literature. World J Surg. 2008;32 (8): 1857–69.

11.

Pidcoke

Wanek

Rohleder

Holcomb

Wolf

Wade

. Glucose variability is associated with high mortality after severe burn. J Trauma. 2009;67 (5): 990–5.

12.

Krinsley

. Glycemic variability: A strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36 (11): 3008–13.

13.

Egi

Bellomo

. Reducing glycemic variability in intensive care unit patients: A new therapeutic target?. J Diabetes Sci Technol. 2009;3 (6): 1302–8.

14.

Kovatchev

Otto

Cox

Gonder-Frederick

Clarke

. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29 (11): 2433–8.

15.

Wolf

Kauvar

Wade

Cancio

Renz

Horvath

White

Park

Wanek

Albrecht

Blackbourne

Barillo

Holcomb

. Comparison between civilian burns and combat burns from Operation Iraqi Freedom and Operation Enduring Freedom. Ann Surg. 2006;243 (6): 786–95.

16.

Mann

Salinas

Pidcoke

Wolf

Holcomb

Wade

. Error rates resulting from anemia can be corrected in multiple commonly used point-of-care glucometers. J Trauma. 2008;64 (1): 15–21.

17.

Mann

Pidcoke

Salinas

Wolf

Wade

Holcomb

. Hematocrit causes the most significant error in point of care glucometers. Crit Care Med. 2009;37 (4): 1530–1.

18.

Krinsley

. Glycemic variability and mortality in critically ill patients: The impact of diabetes. J Diabetes Sci Technol. 2009;3 (6): 1292–301.

19.

Dahagam

Mora

Wolf

Wade

. Diabetes does not influence selected clinical outcomes in critically ill burn patients. J Burn Care Res. 2011;32 (2): 256–62.

20.

Meyfroidt

Keenan

Wang

Wouters

Veldhuis

Van den Berghe

. Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality Crit Care Med. 2010;38 (4): 1021–9.

21.

Hermanides

Vriesendorp

Bosman

Zandstra

Hoekstra

Devries

. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38 (3): 838–42.